Yi Sang
Group President, Asia Pacific
Yi Sang has filed 6 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jun 2, 2026.
On the most recent filing, Yi Sang is listed as Group President, Asia Pacific at ZIMMER BIOMET HOLDINGS, INC. Inside the rolling window, Yi Sang reported no open-market purchases and 3 open-market sales totaling $634K in ZBH. The largest disclosed transaction in the window is a sale of 5,000 ZBH shares on May 29, 2026, worth $413K.
Companies traded
Other insiders at ZBH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$634K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Yi Sang made?
Yi Sang has filed 6 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Yi Sang trade?
Yi Sang has filed SEC Form 4 disclosures for 1 company, including ZBH.
When was Yi Sang's most recent SEC Form 4 filing?
Yi Sang's most recent SEC Form 4 filing on Tracefour is dated Jun 2, 2026.
What is Yi Sang's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Yi Sang is listed as Group President, Asia Pacific.
What is Yi Sang's total buy and sell value in the current window?
Inside the rolling retention window, Yi Sang bought $0 and sold $634K based on SEC Form 4 filings.
What was Yi Sang's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,000 ZBH shares on 2026-05-29, worth $413K, per SEC Form 4 filings.